RTG 300 (Potiga 300 mg)

Generic Name: ezogabine

Pill imprint RTG 300 has been identified as Potiga 300 mg.

Potiga is used in the treatment of seizures; epilepsy and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 300 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).

Potiga

Generic Name:

ezogabine

Imprint:

RTG 300

Strength:

300 mg

Color:

Green

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Neuronal potassium channel openers

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

5 - Some potential for abuse

Manufacturer:

GlaxoSmithKline

National Drug Code (NDC):

00173-0813

Inactive Ingredients:

croscarmellose sodium
FD&C Blue No. 2
hypromelloses
ferric oxide yellow
soya lecithin
magnesium stearate
microcrystalline cellulose
polyvinyl alcohol
magnesium silicate
titanium dioxide
xanthan gum

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.